These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15018641)

  • 1. Differential inhibition of postnatal brain, spinal cord and body growth by a growth hormone antagonist.
    McIlwain DL; Hoke VB; Kopchick JJ; Fuller CR; Lund PK
    BMC Neurosci; 2004 Feb; 5():6. PubMed ID: 15018641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune function in transgenic mice overexpressing growth hormone (GH) releasing hormone, GH or GH antagonist.
    Dialynas E; Brown-Borg H; Bartke A
    Proc Soc Exp Biol Med; 1999 Jul; 221(3):178-83. PubMed ID: 10404033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.
    Yakar S; Setser J; Zhao H; Stannard B; Haluzik M; Glatt V; Bouxsein ML; Kopchick JJ; LeRoith D
    J Clin Invest; 2004 Jan; 113(1):96-105. PubMed ID: 14702113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice.
    Behringer RR; Lewin TM; Quaife CJ; Palmiter RD; Brinster RL; D'Ercole AJ
    Endocrinology; 1990 Sep; 127(3):1033-40. PubMed ID: 2387246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver and kidney growth hormone (GH) receptors are regulated differently in diabetic GH and GH antagonist transgenic mice.
    Chen NY; Chen WY; Kopchick JJ
    Endocrinology; 1997 May; 138(5):1988-94. PubMed ID: 9112397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pre and antenatal elevated and chronic oMt1a-oGH transgene expression on adipose deposition and linear bone growth in mice.
    Oberbauer AM; Cruickshank J; Thomas A; Stumbaugh A; Evans KD; Murray JD; Egan AR
    Growth Dev Aging; 2001; 65(1):3-13. PubMed ID: 11548870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of body growth and adipose deposition effects of growth hormone in oMt1a-oGH transgenic mice.
    Oberbauer AM; Stiglich C; Murray JD; Keen CL; Fong DL; Smith LB; Cushwa S
    Growth Dev Aging; 2004; 68(1):33-45. PubMed ID: 15307663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary morphology of transgenic mice expressing bovine growth hormone.
    Stefaneanu L; Kovacs K; Bartke A; Mayerhofer A; Wagner TE
    Lab Invest; 1993 May; 68(5):584-91. PubMed ID: 8388524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice.
    Chen NY; Chen WY; Striker LJ; Striker GE; Kopchick JJ
    Endocrinology; 1997 Feb; 138(2):851-4. PubMed ID: 9003027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of obesity following inactivation of a growth hormone transgene in mice.
    Pomp D; Oberbauer AM; Murray JD
    Transgenic Res; 1996 Jan; 5(1):13-23. PubMed ID: 8589737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.
    Coschigano KT; Holland AN; Riders ME; List EO; Flyvbjerg A; Kopchick JJ
    Endocrinology; 2003 Sep; 144(9):3799-810. PubMed ID: 12933651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of increased linear bone growth on age at oMT1a-oGH transgene expression in mice.
    Oberbauer AM; Pomp D; Murray JD
    Growth Dev Aging; 1994; 58(2):83-93. PubMed ID: 7928023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.
    Chen NY; Chen WY; Bellush L; Yang CW; Striker LJ; Striker GE; Kopchick JJ
    Endocrinology; 1995 Feb; 136(2):660-7. PubMed ID: 7835300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. II. Skeleton.
    Wolf E; Rapp K; Wanke R; Hermanns W; Pirchner F; von Butler-Wemken I; Brem G
    Growth Dev Aging; 1991; 55(4):237-48. PubMed ID: 1813442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.
    Hoeflich A; Nedbal S; Blum WF; Erhard M; Lahm H; Brem G; Kolb HJ; Wanke R; Wolf E
    Endocrinology; 2001 May; 142(5):1889-98. PubMed ID: 11316754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone transgenes regulate the expression of sex-specific isoforms of 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase in mouse liver and gonads.
    Keeney DS; Murry BA; Bartke A; Wagner TE; Mason JI
    Endocrinology; 1993 Sep; 133(3):1131-8. PubMed ID: 8365357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory effect of human, but not bovine, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice.
    Phelps CJ; Bartke A
    Endocrinology; 1997 Jul; 138(7):2849-55. PubMed ID: 9202227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of growth hormone (GH) in liver regeneration.
    Pennisi PA; Kopchick JJ; Thorgeirsson S; LeRoith D; Yakar S
    Endocrinology; 2004 Oct; 145(10):4748-55. PubMed ID: 15242989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth characteristics of metallothionein-human growth hormone transgenic mice as compared to mice selected for high eight-week body weight and unselected controls. I. Body weight gain and external body dimensions.
    Wolf E; Wanke R; Hermanns W; Brem G; Pirchner F; von Butler-Wemken I
    Growth Dev Aging; 1991; 55(4):225-35. PubMed ID: 1813441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.